Recent advances in the treatment of renal cell carcinoma and the role of targeted therapies

2008 ◽  
Vol 44 (15) ◽  
pp. 2152-2161 ◽  
Author(s):  
Simon Chowdhury ◽  
James M.G. Larkin ◽  
Martin E. Gore
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Targeted Therapies ◽  
Renal Cell ◽  
Recent Advances

Targeted therapies in advanced renal cell carcinoma: the role of metastatic sites as a prognostic factor

2014 ◽  
Vol 10 (8) ◽  
pp. 1361-1372 ◽  
Author(s):  
Paolo Grassi ◽  
Elena Verzoni ◽  
Luca Porcu ◽  
Isabella Testa ◽  
Roberto Iacovelli ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Prognostic Factor ◽  
Cell Carcinoma ◽  
Targeted Therapies ◽  
Renal Cell ◽  
Advanced Renal Cell Carcinoma ◽  
Metastatic Sites

Drug Insight: advances in renal cell carcinoma and the role of targeted therapies

2007 ◽  
Vol 4 (8) ◽  
pp. 470-479 ◽  
Author(s):  
James MG Larkin ◽  
Simon Chowdhury ◽  
Martin E Gore
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Targeted Therapies ◽  
Renal Cell

Targeted therapies for treatment of renal cell carcinoma: recent advances and future perspectives

2015 ◽  
Vol 76 (2) ◽  
pp. 219-233 ◽  
Author(s):  
Joan Minguet ◽  
Katherine H. Smith ◽  
Carsten P. Bramlage ◽  
Peter Bramlage
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Targeted Therapies ◽  
Renal Cell ◽  
Future Perspectives ◽  
Recent Advances

Abstract 3942: The role of vHL and REDD1 in predicting sensitivity to targeted therapies in renal cell carcinoma

2012 ◽  
Author(s):  
Christopher Blick ◽  
Anassuya Ramachandran ◽  
Robert McCormick ◽  
David Cranston ◽  
Adrian L. Harris
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Targeted Therapies ◽  
Renal Cell

scholarly journals miRNAs in Prediction of Prognosis in Clear Cell Renal Cell Carcinoma

2017 ◽  
Vol 2017 ◽  
pp. 1-6 ◽  
Author(s):  
LongJiao Ran ◽  
Jian Liang ◽  
Xin Deng ◽  
JinYu Wu
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Clear Cell ◽  
Common Type ◽  
Cell Renal Cell Carcinoma ◽  
Recent Advances ◽  
Prediction Of Prognosis

Renal cell carcinoma (RCC) is the most common type of urinary malignancy. Clear cell renal cell carcinoma (ccRCC) is the predominant RCC subtype, accounting for 70–80% of RCC. In recent years, miRNAs have been found to be closely associated with the outcome of the patients with ccRCC. In this review, we summarize recent advances in research exploring the role of miRNAs in predicting prognosis in patients with ccRCC.

Sign in / Sign up

Export Citation Format

Share Document